The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Drug-Eluting and Bare Nitinol Stents for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery:Long-term Results From the SIROCCO Trial
Abstract
PURPOSE: To review clinical outcomes of patients with chronic limb ischemia and TASC type C lesions treated with sirolimus-eluting versus bare SMART nitinol self-expanding stents. METHODS: Data were obtained from a randomized, multicenter, double-blinded study conducted in 2 phases. All 93 patients had chronic limb ischemia and superficial femoral artery (SFA) occlusions or stenoses (average lesion length 8.3 cm). In total, 47 patients (31 men; mean age 66.3+/-9.1 years, range 50-84) received the sirolimus-eluting SMART stent and 46 patients (36 men; mean age 65.9 +/-10.8 years, range 38-83) received a bare SMART nitinol stent. Both groups were followed for a mean 24 months. RESULTS: Both the sirolimus-eluting and the bare SMART stents were effective in revascularizing the diseased SFA and in sustaining freedom from restenosis. For both types of stents, improvements in ankle-brachial indices (ABI) and symptoms of claudication were maintained over 24 months (median 24-month ABI 0.96 for the sirolimus group versus 0.87 for the bare stent group, p>0.05). At 24 months, the restenosis rate in the sirolimus group was 22.9% versus 21.1% in the bare stent group (p>0.05). The cumulative in-stent restenosis rates according to duplex ultrasound were 4.7%, 9.0%, 15.6%, and 21.9%, respectively, at 6, 9, 18, and 24 months; the rates did not differ significantly between the treatment groups. The TLR rate for the sirolimus group was 6% and for the bare stent group 13%; the TVR rates were somewhat higher: 13% and 22%, respectively. Mortality rates did not differ significantly between the groups. CONCLUSION: These data demonstrate that the sirolimus-eluting and the bare SMART stent are effective, safe, and free from restenosis in a majority of patients for up to 24 months. Because the restenosis rate in the bare stent group is unexpectedly low, no significant difference could be found between the sirolimus-eluting and the bare SMART stents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery
Schillinger, M., Sabeti, S., Loewe, C., Dick, P., Amighi, J., Mlekusch, W., Schlager, O., Cejna, M., Lammer, J., & Minar, E. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051303 · Cited by 1,157
Self-citationPrevalence and clinical impact of stent fractures after femoropopliteal stenting
Scheinert, D., Scheinert, S., Sax, J., Piorkowski, C., Bräunlich, S., Ulrich, M., Biamino, G., & Schmidt, A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.026 · Cited by 886
Self-citationDuda, S. H., Pusich, B., Richter, G., Landwehr, P., Oliva, V. L., Tielbeek, A., Wiesinger, B., Hak, J. B., Tielemans, H., Ziemer, G., et al. (2002) · Circulation · doi:10.1161/01.cir.0000029746.10018.36 · Cited by 446
Self-citationDrug-eluting stents in vascular intervention
Fattori, R., & Piva, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12275-1 · Cited by 365
Accuracy of lower extremity arterial duplex mapping
Moneta, G. L., Yeager, R. A., Antonovic, R., Hall, L. D., Caster, J. D., Cummings, C. A., & Porter, J. M. (1992) · Journal of Vascular Surgery · doi:10.1016/0741-5214(92)90249-8 · Cited by 228
Lugmayr, H., Holzer, H., Kastner, M., et al. (2002) · Radiology · doi:10.1148/radiol.2221010268 · Cited by 117
Drug-eluting Stents: Potential Applications for Peripheral Arterial Occlusive Disease
Duda, S. H., Poerner, T. C., Wiesinger, B., Rundback, J. H., Tepe, G., Wiskirchen, J., & Haase, K. K. (2003) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000058423.01661.57 · Cited by 102
Self-citationSelf-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results
Mewissen, M. W. (2004) · Techniques in vascular and interventional radiology · doi:10.1053/j.tvir.2004.01.007 · Cited by 100
Cited by
Global Vascular Guidelines on the management of chronic limb-threatening ischemia.
Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., et al. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.02.016 · Cited by 2,015
Global vascular guidelines on the management of chronic limb-threatening ischemia
Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., et al. (2019) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2019.05.006 · Cited by 1,582
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases
Endorsed by: the European Stroke Organisation (ESO), Authors/Task Force Members, Tendera, M., Aboyans, V., Bartelink, M.-L., Baumgartner, I., Clément, D., Collet, J.-P., Cremonesi, A., De Carlo, M., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr211 · Cited by 1,506
Self-citationChorny, M., Fishbein, I., Yellen, B. B., Alferiev, I. S., Bakay, M., Ganta, S., Adamo, R., Amiji, M., Friedman, G., & Levy, R. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909506107 · Cited by 197
Metadata
- Authors
- Duda, S. H., Bosiers, M., Lammer, J., Scheinert, D., Zeller, T., Oliva, V., Tielbeek, A., Anderson, J., Wiesinger, B., Tepe, G., Lansky, A., Jaff, M. R., Mudde, C., Tielemans, H., & Beregi, J.-P.
- Venue
- Journal of Endovascular Therapy
- Published
- 2006-12
- Volume
- 13
- Issue
- 6
- Pages
- 701-710
- ISSN
- 1526-6028 (ISSN-L)
- 1545-1550
- OpenAlex
- W2102187172
- Cited by
- 490
- References
- 8
- FWCI
- 26.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drug-Eluting and Bare Nitinol Stents for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery:Long-term Results From the SIROCCO Trial. https://app.cochat.ai/papers/10.1583/05-1704.1
- The paper
- Duda, S. H., Bosiers, M., Lammer, J., Scheinert, D., Zeller, T., Oliva, V., Tielbeek, A., Anderson, J., Wiesinger, B., Tepe, G., Lansky, A., Jaff, M. R., Mudde, C., Tielemans, H., & Beregi, J.-P. (2006). Drug-Eluting and Bare Nitinol Stents for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery:Long-term Results From the SIROCCO Trial. Journal of Endovascular Therapy. https://doi.org/10.1583/05-1704.1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
